Urinary tract infections have a recurrence rate of up to 35% within six months, and the majority of them are caused by the main pathogenic bacteria. Escherichia coli is a bacterium in the human gut th
New drug development for MM: FDA draft leads the "deep remission" era On January 20, 2026, the FDA released a draft guideline explicitly designating Minimal Residual Disease (MRD) and Complete Respons
Date: February 10, 2026 Summary : The Australian Department of Agriculture, Fisheries and Forestry (DAFF) has issued Import Industry Advice Notice No. 21-2026, announcing upcoming verification inspect
Novo Nordisk's long-acting growth hormone has been approved in China Novo Nordisk's long-acting growth hormone (brand name: Sogroya®/Somapacitan injection) has been approved in China for the treatment
Oral Semaglutide: Weight Loss will Enter an Era of Convenience Semaglutide was initially approved as a treatment for type 2 diabetes. Its mechanism of action involves mimicking the GLP-1 hormone to s
The new drug Culmerciclib has been launched Culmerciclib (brand name: Sitanicina®) is the first global triple inhibitor of CDK2/4/6, developed by Zhengda Tianqing under China Biopharmaceuticals. I
I. Chemical Raw Materials (Approximately 40-45% of Total Consumption) 1. Purified Terephthalic Acid (PTA) Production (Approximately 40-48% of Total Consumption) Application Share: Largest downstream a
About Berberine Hydrochloride Natural Extract Berberine Hydrochloride Natural Extract, as a core alkaloid raw material, holds a significant position in the pharmaceutical industry's intestinal-related
Citric acid (Citric Acid), as the world's largest-produced organic acid, is widely used in food, pharmaceuticals, and chemical industries. Its industrial production is dominated by bio fermentation (a
In 2016, China released the "Healthy China 2030" plan outline. In 2019, the "Opinions on Implementing the Healthy China Action Plan" was released. The most important aspect of the "Healthy China" stra